Why Oppenheimer Global fund is focusing on biotech as rates rise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Equifax (EFX) Tops Q4 EPS by 7c, Beats on Revenues
March 1, 2018 4:41 PM ESTNote: EPS may not be comparable
Equifax (NYSE: EFX) reported Q4 EPS of $1.42, $0.07 better than the analyst estimate of $1.35. Revenue for the quarter came in at $838.5 million versus the consensus estimate of $825.69 million.
Financial Results Summary
The company reported revenue of $838.5 million in the fourth quarter of 2017, a 5 percent increase from the fourth quarter of 2016 and a 4 percent increase in local currency.Fourth quarter diluted EPS attributable to Equifax was $1.42, an increase of 40 percent as compared to the fourth quarter of 2016. Net income attributable to Equifax of $172.3 million was up 40... More